PPARG and diabetic neuropathy: Magnolol showed a great result in improving diabetic neuropathy in mice by reducing mitochondrial dysfunction in DRG neurons via the PPARγ/MKP-7/JNK/SIRT1/LKB1/AMPK/PGC-1α pathway and reducing inflammation through signaling of PPARγ/NF-κB [76].